financetom
Market
financetom
/
Market
/
Rupee falls 13 paise to 73.77 against US dollar in early trade
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rupee falls 13 paise to 73.77 against US dollar in early trade
Sep 24, 2021 4:20 AM

The Indian rupee depreciated 13 paise to 73.77 against the US dollar in opening trade on Friday, in line with other Asian currencies amid a strong greenback in the overseas market. At the interbank foreign exchange, the rupee opened on a weak note and fell to 73.77 against the dollar, registering a decline of 13 paise from the last close, even as the domestic equity market was trading with handsome gains.

Share Market Live

NSE

In the previous session on Thursday, the rupee had settled at 73.64 against the US dollar. Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, rose 0.04 percent to 93.12.

“The Indian rupee opened weaker this Friday against the dollar after benchmark US yields reached their highest level in more than two months on anticipated withdrawal of policy support”, said Sriram Iyer, Senior Research Analyst at Reliance Securities. Most of the emerging market and Asian currencies have started weaker against the dollar this Friday morning and could weigh on sentiments, Iyer added.

Foreign institutional investors were net buyers in the capital market on Thursday as they purchased shares worth Rs 357.93 crore, as per exchange data. On the domestic equity market front, the 30-share Sensex was trading 332.43 points or 0.56 percent higher at 60,217.79. In initial deals, the benchmark index had touched a lifetime high of 60,333.

Similarly, the broader NSE Nifty was trading 86.20 points or 0.48 percent up at 17,909.15. In early deals the wide-based index had touched a record 17,947.65.

Global oil benchmark Brent crude futures advanced 0.13 percent to USD 77.35 per barrel.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket
Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket
Dec 13, 2024
08:05 AM EST, 12/13/2024 (MT Newswires) -- US stock futures were rising in Friday's premarket session as investors looked to end the week on a positive note. Dow Jones Industrial Average futures were up 0.14%, S&P 500 futures gained 0.35%, and Nasdaq futures were rising 0.78%. Oil prices were moving higher, with front-month global benchmarks Brent crude and West Texas...
Sector Update: Tech
Sector Update: Tech
Dec 13, 2024
08:44 AM EST, 12/13/2024 (MT Newswires) -- Technology stocks were advancing premarket Friday as the Technology Select Sector SPDR Fund (XLK) was 1% higher and the SPDR S&P Semiconductor ETF (XSD) was up 2.9% recently. Broadcom ( AVGO ) shares rose past 17% after the company reported higher fiscal Q4 non-GAAP net income and revenue. The company also raised its...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Eye Third Rate Cut
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Eye Third Rate Cut
Dec 13, 2024
08:42 AM EST, 12/13/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.9% in Friday's premarket activity as investors eyed a third interest rate cut by the US Federal Reserve before the year ends. US stock futures were also higher,...
Sector Update: Health Care
Sector Update: Health Care
Dec 13, 2024
08:53 AM EST, 12/13/2024 (MT Newswires) -- Health care stocks were steady premarket Friday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) inactive. BeiGene ( BGNE ) shares were up over 2% after the company said overnight it signed a global licensing deal with CSPC Zhongqi Pharmaceutical Technology for its experimental cancer therapy, SYH2039....
Copyright 2023-2026 - www.financetom.com All Rights Reserved